Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER). (Q50724452)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 February 2014

Language	Label	Description	Also known as
English	Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).	scientific article published on 7 February 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

multicenter clinical trial

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Thomas Filleron

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Thomas Bachelot

2

object named as

Thomas Bachelot

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Frederic Commo

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Mario Campone

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Monica Arnedos

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Véronique Dieras

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Magali Lacroix-Triki

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ludovic Lacroix

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Pascale Cohen

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

David Gentien

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jose Adélaide

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Florence Dalenc

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Anthony Goncalves

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Christelle Levy

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jean-Marc Ferrero

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jacques Bonneterre

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Claudia Lefeuvre

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Marta Jimenez

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Hervé Bonnefoi

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

7 February 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

267-274

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The landscape of cancer genes and mutational processes in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Biology-driven phase II trials: what is the optimal model for molecular selection?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A probe-density-based analysis method for array CGH data: simulation, normalization and centralization.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A faster circular binary segmentation algorithm for the analysis of array CGH data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogene addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970611-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(13)70611-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24508104%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50724452&oldid=1967186259"